Long acting insulin (Daewoong Pharmaceutical)

N/A

Report date: 2025/03/31 16:54:13

Base Information

Drug NameLong acting insulin (Daewoong Pharmaceutical)
Drug Alias NameDWP-457
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionOrnithine decarboxylase stimulantsProtein-tyrosine kinases inhibitorsPhosphokinases stimulants
TargetsProtein-tyrosine kinasesOrnithine decarboxylasePhosphokinases
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaewoong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A